Your Article Summary
Clinical Development in the Nordic Region & Northern Europe
PharmiWeb, 12/01/08
The Nordic and Northern European region is widely regarded as a very attractive location to run clinical studies. However, like other western European countries, clinical site saturation is becoming an important issue in this region as the number of studies increase, as well as their complexity. Nordic and Northern European countries must maintain their competitive edge in contrast to other emerging clinical regions with larger, treatment naive patient populations.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09
Sanofi-aventis and US biopharmaceutical company Micromet sign global collaboration and license agreement for new solid tumor BiTE antibody
Sanofi-aventis, 10/30/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Forest Laboratories, 10/29/09
Article Search
Sponsor


See Latest Articles


